Production (Stage)
Tharimmune, Inc.
THAR
$1.36
-$0.0124-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.70% | 14.53% | 16.71% | 3.03% | -20.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.49% | 52.00% | 109.51% | 0.38% | -13.52% |
| Operating Income | -8.49% | -52.00% | -109.51% | -0.38% | 13.52% |
| Income Before Tax | -12.66% | -54.44% | -108.55% | 0.50% | 16.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.66% | -54.44% | -108.55% | 0.50% | 16.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.66% | -54.44% | -108.55% | 0.50% | 16.08% |
| EBIT | -8.49% | -52.00% | -109.51% | -0.38% | 13.52% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 61.22% | 79.99% | 93.78% | 95.36% | 97.09% |
| Normalized Basic EPS | 61.21% | 79.99% | 93.78% | 95.36% | 97.09% |
| EPS Diluted | 61.22% | 79.99% | 93.78% | 95.36% | 97.09% |
| Normalized Diluted EPS | 61.21% | 79.99% | 93.78% | 95.36% | 97.09% |
| Average Basic Shares Outstanding | 190.47% | 671.94% | 3,249.13% | 2,042.76% | 2,785.02% |
| Average Diluted Shares Outstanding | 190.47% | 671.94% | 3,249.13% | 2,042.76% | 2,785.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |